Liquidia (LQDA) Assets (2019 - 2026)
Liquidia's (LQDA) quarterly Assets came in at $401.5 million in Q1 2026, up 76.55% year-on-year from $227.4 million in Q1 2025, and up 22.44% quarter-over-quarter from $327.9 million in Q4 2025.
Liquidia (LQDA) Assets (2019 - 2026) Analysis & Trends
Liquidia's Assets history runs 8 years deep, the most recent figure standing at $401.5 million for Q1 2026.
- On a quarterly basis, Assets rose 76.55% year-over-year to $401.5 million in Q1 2026; TTM through Mar 2026 was $401.5 million, a 76.55% increase from a year earlier, with the FY2025 full-year figure at $327.9 million, up 42.39% from the prior year.
- Assets climbed to $401.5 million in Q1 2026 per LQDA's latest filing, from $327.9 million in the prior quarter.
- Across five years, Assets topped out at $401.5 million in Q1 2026 and bottomed at $93.5 million in Q1 2022.
- The 5-year median for Assets is $177.4 million (2024), against an average of $195.5 million.
- Across the five-year window, Assets retreated 15.79% in 2023 and surged 126.52% in 2024, its largest moves.
- Year by year, Assets stood at $129.2 million in 2022, then declined by 8.41% to $118.3 million in 2023, then surged by 94.63% to $230.3 million in 2024, then soared by 42.39% to $327.9 million in 2025, then increased by 22.44% to $401.5 million in 2026.
- Per Business Quant, the three latest LQDA Assets figures stand at $401.5 million (Q1 2026), $327.9 million (Q4 2025), and $276.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 401.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 401.53 Mn |
| Dec 31, 2025 | 327.93 Mn |
| Sep 30, 2025 | 275.98 Mn |
| Jun 30, 2025 | 257.41 Mn |
| Mar 31, 2025 | 227.43 Mn |
| Dec 31, 2024 | 230.31 Mn |
| Sep 30, 2024 | 252.89 Mn |
| Jun 30, 2024 | 177.36 Mn |
| Mar 31, 2024 | 197.12 Mn |
| Dec 31, 2023 | 118.33 Mn |
| Sep 30, 2023 | 111.64 Mn |
| Jun 30, 2023 | 121.60 Mn |
| Mar 31, 2023 | 128.92 Mn |
| Dec 31, 2022 | 129.20 Mn |
| Sep 30, 2022 | 132.57 Mn |
| Jun 30, 2022 | 139.08 Mn |
| Mar 31, 2022 | 93.53 Mn |
| Dec 31, 2021 | 93.73 Mn |
| Sep 30, 2021 | 100.30 Mn |
| Jun 30, 2021 | 104.38 Mn |